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We have generated a transgenic rat model using RNAi and used it to
study the role of themembrane protein Nogo-A in synaptic plasticity
and cognition. The membrane protein Nogo-A is expressed in CNS
oligodendrocytes and subpopulations of neurons, and it is known
to suppress neurite growth and regeneration. The constitutively
expressed polymerase II-driven transgenewas composed of a micro-
RNA-targeting Nogo-A placed into an intron preceding the coding
sequence for EGFP, thus quantitatively labeling cells according to in-
tracellular microRNA expression. The transgenic microRNA in vivo
efficiently reduced the concentration of Nogo-A mRNA and protein
preferentially in neurons. The resulting significant increase in long-
term potentiation in both hippocampus and motor cortex indicates
a repressor function of Nogo-A in synaptic plasticity. The transgenic
rats exhibited prominent schizophrenia-like behavioral phenotypes,
such as perseveration, disrupted prepulse inhibition, and strong
withdrawal from social interactions. This fast and efficient micro-
RNA-mediated knockdown provides a way to silence gene expres-
sion in vivo in transgenic rats and shows a role of Nogo-A in
regulating higher cognitive brain functions.
animal model | Rtn4 | learning | memory
Gene knockout (KO) technology has spurred the analysis ofgene functions in mice during the past two decades (1) and
has recently been expanded to other species using new genome
modification technologies (2). Although germ-line gene ablation
is a very powerful tool for investigating gene function in vivo, its
most important drawback is that the complete loss of gene func-
tion often leads to molecular compensation, obscuring the role of
the deleted gene. Tissue- or cell-specific KOs are more specific
but are currently confined to mice as a model system. RNA in-
terference (RNAi) is a viable alternative to the KO approach and
represents a fast and powerful tool for manipulating gene ex-
pression (3). RNAi technology not only allows keeping the en-
dogenous genomic locus intact, but it also enables the knockdown
of multiple genes at the same time or the selective depletion of
a specific isoform of mRNA transcripts (4). Another advantage is
offered by the possibility of creating hypomorphic alleles instead
of complete KOs, which can avoid embryonic lethality and better
mirrors many human diseases and therapeutic interventions.
Elucidating gene functions in transgenic rats has several im-
portant advantages over using mice (5). Their larger size simplifies
interventions, such as microsurgery and multiple site in vivo elec-
trophysiological recordings (6). Furthermore, higher-order cogni-
tive functions are more developed in this social rodent species than
in the more solitarily living mice (7, 8). Hence, many behavioral
tests are more advanced or validated for the rat species, especially
regarding the behavioral assessment of complex neuropsychiatric
disease phenotypes, such as negative symptoms in schizophrenia.
For the rat, only polymerase (Pol) III-controlled shRNA RNAi
models have been created, but this methodology does not easily
allow for tissue-specific or simultaneous expression of translated
mRNAs (9). MicroRNAs (miRNAs) (10) can be efficiently
expressed by Pol II promoters in eukaryotic cells and a tissue-
specific manner (11). Similar to shRNAs, miRNAs bind a defined
target site in an endogenous mRNA, leading to efficient knock-
down of target genes (12). In mice, transgenic RNAi expression
not only led to phenotypes that closely resembeled those observed
in KO mice (13, 14) but also enabled the generation of hypo-
morphic animal models (14).
In this study, we present and investigate the potential of Pol II-
driven knockdown in a rat model that quantitatively monitors the
transgenic miRNA expression using EGFP as a reporter. Such
cellular visualization facilitates selection and analysis of transgenic
animals and targeted cell populations, opening avenues for ad-
ditional cellular analysis in vivo. As an experimental example, we
created Nogo-A (Rtn4) knockdown rats using this technology. In
these rats, we found enhancement of long-term potentiation (LTP)
in not only hippocampus but also cortex, and we observed be-
havioral phenotypes related to schizophrenia, extending those
phenotypes described in the Nogo-A KO mouse (15). These
findings validate the miRNA-based knockdown technology and
show an important role of Nogo-A repressing neuronal plas-
ticity. Moreover, unlike Nogo-A KO mice, which show a signifi-
cant Nogo-B up-regulation, there is no such compensatory mech-
anism apparent in our transgenic model.
Results
Design of the miRNA Expression Unit and Generation of Nogo-A
Knockdown Rats. To determine the most efficient expression de-
sign of Pol II-driven miRNAs, we first tested two constructs, in
which the miRNA was located in either the 3′ UTR of EGFP
(pUTR) or an intronic sequence located 5′ of EGFP (pINTRON)
(11). The intronic design enables about fourfold higher knockdown
efficacy compared with 3′ design coupled with high expression
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of miRNA/EGFP (Fig. 1A). Different synthetic siRNAs se-
lectively targeting Nogo-A mRNA were tested for knockdown
efficiencies by transient transfections of oligonucleotides into
3T3 fibroblasts, which express Nogo-A endogenously. The
most efficient RNAi sequence was chosen for the design of
a miRNA targeting Nogo-A mRNA, which was then cloned
into the intronic sequence of the vector pINTRON (Fig. 1A).
Placing the miRNA sequences in an intron ensures effective
labeling of the miRNA-expressing cells with EGFP, while at
the same time, enhances and stabilizes transgenic expression
(16). For strong transgenic expression of the miRNA targeting
Nogo-A, we replaced the human cytomegalovirus (CMV) pro-
moter of pINTRON with a hybrid construct comprising the CMV
early enhancer element and the chicken β-actin (CAG) promoter
(17). ThemiRNA is transcribed as bifunctional pre-mRNA coding
for EGFP, which is processed into functional miRNA and equi-
molar amounts ofEGFPmRNA. To test the knockdown efficiency
of the final construct, we transfected 3T3 fibroblasts and quan-
tified endogenous Nogo-A mRNA 3 d posttransfection; 91% of
the Nogo-A mRNA expression was abolished compared with
control conditions (Fig. 1B, Inset).
For the production of transgenic rats, the pCAG-INTRON-
(miRNA Nogo-A)-EGFP DNA construct was microinjected into
fertilized Sprague–Dawley rat oocytes, resulting in the generation
of eight individual founders. Primary fibroblast cultures were
established from ear punches of these animals (18) and tested for
EGFP fluorescence. The four founders with strongest EGFP ex-
pression in fibroblasts were mated with WT Sprague–Dawley
animals to establish the respective lines L2, L3, L18, and L33.
From those four lines, L2, L3, and L18 transmitted the transgene
in Mendelian fashion and therefore were chosen for detailed
analysis. To validate CAG promoter activity in the CNS, we ana-
lyzed EGFP expression in brain lysates and on histological brain
sections. Western blot analyses showed expression of EGFP in all
brain regions tested; the expression was strongest in line L2 (Fig.
2A). To assess functional processing of the transgenic miRNA
targeting Nogo-A, we quantified the absolute number of Nogo-A
miRNA copies per cell in spinal cord, cortex, and hippocampus
RNA preparations by quantitative PCR (qPCR) (Fig. 2B). As
expected, RNA preparations from L2 rats contained the highest
concentration of transgenic miRNA, being at least fivefold above
the content of all other lines in the examined regions. To ensure
that overexpression of the transgenic miRNA had no influence on
the overall miRNA-processing machinery (19), we compared the
expression profiles of 359 abundantly expressed miRNA sequen-
ces in L2 and WT rats (Fig. 2C). The results show that the trans-
genic miRNA did not influence endogenous miRNA expression
and thus, did not interfere with the overall miRNA-processing
machinery. Histological sections of the brains of L2 rats revealed
that, in the cortex, 48.8% (±7.8%, n = 5) and in the hippocampus,
72.8% (±11.2%, n = 6) of neuronal nuclei (NeuN)-positive neu-
rons expressed EGFP (Fig. 2 D and E). Expression was also de-
tectable in blood vessels (Fig. 2D) but absent in the vast majority of
oligodendrocytes and interneurons (Fig. S1).
Nogo-A Levels Are Significantly Diminished in L2 Animals. qPCR
revealed significant reduction of Nogo-A mRNA in several CNS
regions in L2 and L3 rats to about 50% and 75% of WT levels,
respectively (Fig. S2). Nogo-A protein expression was assessed by
Western blotting (for determination of dynamic range, see Fig. S3)
and immunofluorescence analysis in different regions of the CNS
of adult L2 and L3 transgenic rats. Western blots revealed a re-
duction ofNogo-A expression in the cortex of L2 rats to about 30%
of WT mean but no detectable decrease in the cortex of L3 rats.
Importantly, Nogo-B expression remained unchanged in both
transgenic lines (Fig. 3A). Hippocampal Nogo-A expression was
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Fig. 1. Design and testing of the intronic miRNA/EGFP ex-
pression system. (A) Expression vectors pUTR and pINTRON
containing a rationally designed miRNA targeting firefly
luciferase (M) or no miRNA as controls (E). In pUTR, the
miRNA is integrated between the 3′ end of EGFP and the
polyadenylation signal (pA). In pINTRON, the miRNA is em-
bedded within an artificial intron located 5′ of EGFP. Tran-
sient transfection experiments using miRNA/EGFP together
with luciferase expression vectors show that relative EGFP
activities and luciferase knockdown efficiencies are much
higher for pINTRON than pUTR. Means (n = 9) and SEM are
shown. (B) Schematic drawing of the Nogo-A miRNA insert-
containing construct used for the generation of transgenic rats. Inset displays results of Nogo-A qPCR quantification relative to housekeeping genes from
Nogo-A–expressing 3T3 cells transfected with either pCAG-INTRON-(miRNA Nogo-A)-EGFP (KD) or control (C) vector. ***P < 0.001.
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Fig. 2. Rat line L2 expresses transgenic EGFP and
miRNA at the highest level without affecting the miRNA-
processing machinery. (A) Western blot results of EGFP
and GAPDH for different CNS regions derived from the
transgenic rat lines L2, L3, and L18 as well as WT rats. Cb,
cerebellum; Ctx, cortex; Hip, hippocampus; SC, spinal cord.
(B) Absolute qPCR quantification (expressed as molecules
per cell) of transgenic Nogo-A miRNA expression levels
in different rat lines and CNS regions. (C ) Scatter plot
of qPCR expression levels of 359 abundantly expressed
miRNAs from L2 and WT rats. Nonregulated miRNA levels
of L2 vs. WT are identical and converge on the bisector of
the angle. (D and E) Immunofluorescence of EGFP (green)
and the neuronal nuclear marker neuronal nuclei
(NeuN) (red) in the cortex (D) and hippocampus (E ) of
L2 shows a largely neuronal expression of the transgene.
(Scale bar: D, 50 μm; E, 20 μm.) *P < 0.05; **P < 0.01.
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reduced by 30% in L2 rats (Fig. 3A). More detailed results were
obtained from densitometric measurements of L2 histological
brain sections, where Nogo-A expression was quantified by im-
munofluorescence. Here, the cingulate cortex of L2 rats showed
a decrease of Nogo-A expression to 70%, and the motor cortex to
40% of WT levels (Fig. 3 B and C). The densitometric meas-
urements revealed a major loss of Nogo-A expression in neurons
(Fig. 3 B and C). Quantified Nogo-A levels were 40% of WT in
the hippocampus, 45% of WT in the caudate-putamen, and
in total, about 60% of WT in the cerebellum. In the spinal cord,
Nogo-A expression decreased to 40–50% in motor neurons,
whereas expression was not significantly changed in white matter
oligodendrocytes of L2 animals (Fig. 3 B and C). Treatment of
spinal cord slices with ethanol and acetic acid known to spe-
cifically visualize Nogo-A expression in myelin (20) confirmed
retention of Nogo-A expression in oligodendrocytes of L2 rats
(Fig. 3 B and C).
Overall, although regional variations were noted, transgenic rat
line L2 with the highest miRNA expression showed about 50%
reduction of Nogo-A protein expression in CNS neurons. Copy
number quantification of transgenic insertions into the genome
of L2 showed six copies per cell (Fig. S4). We selected L2 for
additional behavioral and electrophysiological experiments.
Nogo-A–Deficient Rats Exhibit Distinct Behaviors Resembling
Neuropsychiatric Phenotypes. Cohorts of L2 and WT animals
(n = 10 each) were used to investigate the consequences of re-
duced Nogo-A expression on behavior. We focused on the anal-
ysis of distinct neuropsychiatric intermediate phenotypes, some of
which have been associated with Nogo-A function in a KO
mouse model (15). Baseline behavioral parameters like loco-
motor activity were similar in L2 and WT rats (Fig. 4A). The two
groups were indistinguishable in terms of anxiety-related be-
havior, deduced from the time spent in the center of the open
field and the elevated plus maze task (Fig. S5 A and B).
However, when animals were tested for their sensorimotoric
gating, a marked deficit in prepulse inhibition (PPI) could be
observed in L2 rats compared with WT controls [FGenotype(1.54) =
4.97; P = 0.039] (Fig. 4B). Cognitive functions of the animals
were evaluated using the novel object recognition and the object
relocation paradigms. In these tasks, the animal had to distin-
guish a novel or relocated object from familiar objects that it had
memorized. L2 animals displayed significantly decreased short-
term memory capabilities compared with WT controls in dis-
criminating both a novel object (Fig. 4C) and a relocated object
(Fig. 4D) from a familiar one. No significant differences were
observed between the animals of both genotypes regarding object
exploration time during the training phase of the tasks. Behav-
ioral differences between L2 rats and controls were also observed
during testing of social interaction. A significant decrease in total
social interaction was observed in L2 rats compared withWT (Fig.
S5C). This difference originated only from a highly significant
decrease in nonanogenital exploration, because no significant
differences between the groups were detected for anogenital ex-
ploration and following/approach during interaction with the
unfamiliar social partner (Fig. 4E). L2 rats showed a strong ten-
dency for lower social contact behaviors compared with WT
animals (P = 0.054) (Fig. 4F). Finally, L2 rats were found to
withdraw significantly more often from social contact if initiated
by the social partner (social evade) (Fig. 4G). No significant dif-
ferences between the groups were detected for self-grooming
behavior (Fig. S5D). Spatial learning and behavioral flexibility
were assessed in a reversal learning paradigm using a water T
maze. Performance during the initial learning of the task was
indistinguishable between rats of both genotypes (Fig. S5E).
However, L2 rats showed perseveration in reversal learning, re-
quiring one additional trial for the reversal of the escape strategy
compared with WT rats (Fig. 4H and Fig. S5 F and G).
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Fig. 3. Expression of Nogo-A is reduced in L2 rats.
(A) Western blot analysis of Nogo-A (∼200 kDa)
and Nogo-B (∼50 kDa) expression compared with
GAPDH (∼40 kDa) in different CNS tissues. Whereas
Nogo-A is significantly down-regulated in the cor-
tex of L2 rats (P = 0.0173), no cortical knockdown
can be seen in animals of L3. In addition, Nogo-B
remains unchanged in both L2 and L3. Nogo-A
knockdown can also be observed in the hippo-
campus (P = 0.0195) of L2 rats, whereas only
a trend is visible in whole spinal cord (P = 0.0659).
Averaged Nogo-A/GAPDH ratios from three ani-
mals per transgenic line or WT are reported as
a percentage of WT mean ± SEM. (B) Densitometric
quantification of Nogo-A immunoreactivity as de-
termined by epifluorescence microscopy in a Zeiss
Axiophot microscope. Down-regulation of Nogo-A
is evident in the cingulate (CC; P = 0.0499) and
motor cortex (MC; P = 0.0041) of L2 rats. In addi-
tion, Nogo-A immunoreactivity is decreased in the
cell layers of the hippocampus (Hip; P = 0.0080) and
the caudate putamen (CPu; P = 0.0008). Down-
regulation can also be observed in the cerebellar
white matter (WM; P = 0.0166), whereas only
a trend is seen in the molecular layer (ML; P =
0.2155), Purkinje cell layer (PCL; P = 0.1675), and
granular cell layer (GCL; P = 0.2310). In the spinal
cord, whereas a marked reduction of Nogo-A im-
munoreactivity is detected in motoneurons (MNs;
P < 0.0001), no significant change can be observed
in spinal oligodendrocytes (ODCs; P = 0.1135). Sim-
ilar results were obtained after ethanol/acetic acid
treatment (EtOH/AcOH) of the spinal cord sections
(MN, P = 0.0002; ODC, P = 0.2449). (C) Representative confocal images show the decrease of Nogo-A immunoreactivity in L2 rats in different CNS regions.
Images of the spinal cord show sections after EtOH/AcOH treatment. (Scale bars: 50 μm.) Data are presented as mean + SEM. Asterisks represent P values
obtained by comparing L2 and WT rats with unpaired t test: *P < 0.05; **P < 0.01; ***P < 0.001.
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Reduced Nogo-A Expression Results in Increased Synaptic Plasticity in
the Hippocampus and Motor Cortex. Because Nogo-A expression is
high in hippocampus and primarymotor cortex (M1) neurons (20)
(Fig. 3), we used our transgenic rat model to investigate the role of
Nogo-A in regulating synaptic transmission and plasticity in these
areas. To assess baseline synaptic transmission at the hippocam-
pal CA3-CA1 Schaffer collateral pathway, input–output curves
were generated by measuring evoked field excitatory postsynaptic
potential (fEPSP) slopes at increasing stimulation intensities (20–
100 μA). No difference was seen between the L2 and WT rats
(Fig. 5A). To analyze the influence of Nogo-A on short-term
plasticity, we measured paired pulse facilitation by applying two
stimuli separated by a temporal interstimulus interval of 40 ms
and recorded fEPSPs. We obtained slightly higher paired pulse
ratios for the L2 line (Fig. 5B), which were, however, not signifi-
cantly different from the ratios of control littermates (L2: 1.47 ±
0.07 SEM; WT: 1.24 ± 0.08; P = 0.13). To investigate the role of
Nogo-A in regulating hippocampal synaptic plasticity, we induced
LTP using a theta-burst stimulation (TBS) protocol after 20 min of
baseline recordings. We observed a significant increase in LTP in
L2 rats (157.5 ± 0.76%, n = 4) compared with littermate controls
(132.2± 1.9%, n= 4; P< 0.05) (Fig. 5C). To determine whether the
presence of Nogo-A in M1, a structure involved in motor skill ac-
quisition (21), is relevant for synaptic transmission and/or synaptic
plasticity, we measured evoked fEPSPs in layer II/III horizontal
connections in acute brain slices containing the M1 forelimb area.
Baseline synaptic transmission as determined by input–output
relationships using multiples of threshold intensity was not affected
in Nogo-A–deficient rats (Fig. 5D). fEPSP amplitudes were not
significantly different in L2 vs. WT rats (3× threshold intensity: L2:
0.64 ± 0.035 mV; WT: 0.69 ± 0.037 mV; P = 0.35; n = 15).
The maximum potential for synaptic plasticity was determined
by multiple attempts of LTP. After 20 min of baseline recordings
at 50% maximum response amplitude, LTP was induced by TBS
preceded by local transient application of the GABAA receptor
antagonist bicuculline (22). This stimulation protocol was re-
peated until responses did not increase. Maximum synaptic
strength (LTP saturation) was significantly increased in L2 rats
(152 ± 5.9%; n = 16) compared with WT rats (122 ± 5.5%; n =
15; P = 0.001) (Fig. 5E), suggesting that Nogo-A is a repressor of
synaptic plasticity in the motor cortex as well.
Discussion
Nogo-A is an important neurite growth inhibitory protein that
stabilizes the adult CNS wiring, restricts regeneration, and also
negatively regulates hippocampal plasticity (23). Recent evidence
suggests that aberrant Nogo-A signaling poses an increased risk
for schizophrenia (detailed review in ref. 24). We applied a Pol II-
driven miRNA expression strategy for RNAi-mediated mRNA
knockdown in transgenic rats, resulting in an ∼50% reduction of
neuronal Nogo-A protein in different regions of the CNS. The rat
model that we present here extended the range of schizophrenia-
like phenotypes previously reported for conventional Nogo-A KO
mice and allowed for amore detailed investigation of learning and
memory-related phenotypes. RNAi-mediated genetic depletion
of Nogo-A significantly increased synaptic plasticity in not only
the hippocampus but also the motor cortex.
Pol II-Driven Expression of Intronic Synthetic miRNA Induces Down-
Regulation of the CNS Protein Nogo-A. Traditionally, rats have been
the preferred experimental animal model system in biomedical
research (25), particularly for the analysis of complex neurological
disorders and behavioral psychology, where they are superior to
mice inmany respects (26). Pol II-basedmiRNAexpression systems
are a reverse genetic strategy for overexpression of miRNAs. In our
experiments, placing an miRNA sequence into an intron 5′ of
a coding gene significantly enhances expression compared with 3′
insertions and at the same time, enables simultaneous expression of
Pol II-controlled genes. EGFP coexpressionwith a similar construct
in mice failed so far (14), and in rats, only shRNAs driven by a Pol
III human H1 promoter have been successfully applied (9, 27). The
latter method does not allow quantitative coexpression of an in-
terferingRNA together with a protein coding gene or tissue-specific
gene expression. We inserted the Nogo-A–targeting miRNA in an
intronic sequence preceding the ORF of EGFP in the vector
pCAG-INTRON-EGFP (11). The CAG promoter has been
shown to be well-suited for transgenic expression in rats, par-
ticularly for neurons (28–30). This construct enables labeling
of miRNA-expressing cells and a quantitative measure of the
amount of miRNA produced (Fig. S6), because the miRNA is
spliced from the EGFP mRNA. An overall reduction of Nogo-A
mRNA and protein levels by 50% in several regions of the CNS
of adult rats was achieved in line L2.
Reduced Nogo-A Expression Leads to Defects in Cognition,
Sensorimotor Gating, and Social Behavior. Rat transgenic line L2
with high neuronal and not detectable oligodendrocytic EGFP
reporter expression was chosen for in-depth analyses. Immuno-
histochemistry detecting Nogo-A confirmed the significant Nogo-A
depletion in neurons. Behaviorally, these rats showed disruptions in
sensorimotor gating and selective attention, and an increased
perseverative behavior in reversal learning was observed. These
changes are hallmarks for schizophrenia (31). Indeed, similar
phenotypes were recently observed in conventional Nogo-A KO
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Fig. 4. L2 rats exhibit schizophrenia-like phenotypes. (A) Locomotor activity
in the open field arena. No difference on distance traveled between WT and
Nogo-A knockdown rats (L2). (B) PPI. Two-way ANOVA revealed a significant
reduction in PPI in L2 rats compared with WT rats [FGenotype (1,54) = 4.97; P =
0.039]. However, Bonferroni posthoc testing revealed that, only at a PPI of 70
dB (PPI-70), startle amplitudes of L2 rats were significantly lower than those
startle amplitudes of WT rats. (C) Effects of Nogo-A knockdown on novel
object recognition memory in the novel object recognition task. L2 and WT
rats showed no significant differences in percent of time spent in exploration
of the identical objects (IOs) during the training phase of the test. In contrast,
L2 rats have a significant impairment in discriminating between the novel and
the familiar object during testing (NO). (D) Novel object relocation task. L2
and WT rats showed no significant differences in exploration of the IOs
during the training phase of the test. During the test phase, L2 rats had
a significant impairment in discriminating the relocated object (RO). (E–G)
Behavioral performance during social interaction with an unknown social
partner (social interaction). (E) Significant differences between WT and L2
rats were found for nonanogenital exploration (non-AG), whereas no dif-
ferences were observed for anogenital exploration (AG) and following/ap-
proach (FA). (F) A strong trend was found for a decrease in the number of
social contact behaviors (grooming/crawling). (G) L2 rats show significantly
more social withdrawal behavior thanWT littermates. (H) Reversal learning in
the water T maze. Two-way ANOVA revealed that there was no significant
difference between animals of the two genotypes in the reversal of their
escape strategy in thewater Tmaze, whichwas seen from their percentage of
correct trails within the task [L, FGenotype(1.108) = 1.22; P = 0.284]. In contrast,
Bonferroni posthoc testing revealed that, in trial 2, L2 rats have a significant
impairment in finding the escape platform. All data are mean values ± SEM.
Asterisks represent P values obtained by comparing L2 and WT rats with
either unpaired t or Bonferroni posthoc test after two-way ANOVA of re-
peated measures: *P < 0.05; **P < 0.01; ***P < 0.001.
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mice (15). Compared with the mouse model, unique phenotypic
traits could be identified in our transgenic Nogo-A knockdown rats:
they showed significantly lower exploration and reduced social
contact behavior as well as much higher withdrawal from social
interaction initiated by the social partner compared with their WT
littermates. The presence of these negative symptoms in the rat
model is of particular significance. In free social interactions, L2
rats showed normal exploratory behavior but a marked attenuation
and avoidance of social contact. Although such social withdrawal
behavior might be related to increased anxiety (32), we consider
it unlikely, because in the open field test and the elevated plus
maze task L2 rats showed no signs of anxiety and Nogo-A KO
mice do not differ in anxiety-related behaviors from their WT
controls (33). Social withdrawal and isolation are among the key
components of negative symptoms in schizophrenia (34), and
thus, social withdrawal observed in L2 rats supports a schizo-
phrenia-like phenotype.
Current pharmacological treatments are focusing on the posi-
tive symptoms of schizophrenia in man, because genetic mouse
models were quite successful in modeling these symptoms (35). In
contrast, only very few mouse models exhibit the negative symp-
toms associated with this disease (36, 37). The Nogo-A knock-
down rat with both positive and negative schizophrenia-like
symptoms may provide a tool for testing compounds selective for
negative symptoms, the severity of which is most predictive for
poor therapeutic outcome in patients (38).
Nogo-A Is a Negative Regulator of Synaptic Plasticity in the
Hippocampus and Motor Cortex. Depletion of Nogo-A might affect
the synaptic equilibrium, resulting in the observed behavioral dys-
functions. In schizophrenic patients, increased hippocampal activity
at baseline and during auditory hallucinations is often observed (39,
40). We have recently found significantly increased LTP in mouse
hippocampal slices treated with Nogo-A blocking antibodies and
a trend for increased hippocampal LTP in Nogo-A KO mice (41).
Here, we show that rats with reduced neuronal Nogo-A expression
exhibit a significant increase in hippocampal LTP compared with
WT littermates. To determine whether synaptic plasticity was gen-
erally changed in these animals, wemeasured cortical LTP induction
after saturated TBS in the primary motor cortex, a region critically
important for motor learning, which correlates with increased LTP
(21). After TBS of horizontal connections, LTP was doubled in
Nogo-A knockdown rats compared with WT littermates. These
results show that neuronal Nogo-A mediates repression of synaptic
plasticity in the hippocampus and the motor cortex, probably by
regulating synapse maturation, size, and/or numbers (42, 43).
Inhibitory constraints on synaptic plasticity and learning and
memory were shown in Aplysia, Drosophila, mice, and humans
(44–46); removal of such molecular constraints can result in in-
creased synaptic plasticity and improved learning and memory
(47–49). Although generally increased hippocampal LTP corre-
lates with improved learning and memory, pathological and pro-
longed increase in LTPmay also lead to cognitive defects (50–54).
The perseveration that we observed could indicate an effect of
Nogo-A knockdown on memory, which is currently being ana-
lyzed in more detail. However, the LTP results would also be
consistent with detrimental effects on cognitive functions. Nogo-
A knockdown rats, KO mice, and in vivo neutralization experi-
ments with antibodies can now be used to further analyze the roles
of neuronal Nogo-A for learning, memory and cognitive func-
tions, and neuropsychiatric diseases, particularly schizophrenia.
Specific Advantages of miRNA Knockdown Transgenic Rats. Com-
pensation and lethality are frequent undesirable side effects of
conventional KO mice. In Nogo-A KO mice (55–57), significant
up-regulation of the small splice-isoform Nogo-B was found (58),
whereas Nogo-B was not affected in our transgenic Nogo-A
knockdown rats. One reason might be that the miRNA-based ap-
proach targets splice form-specific mRNAs and leaves the endog-
enous genetic locus intact. Reducing the concentration of a target
protein rather than completely removing itmay also help to prevent
compensation and particularly, also lethality. Importantly, partial
knockdowns also mirror some human pathologic conditions more
accurately, especially conditions caused by hypomorphic muta-
tions, epigenetic silencing events, or altered RNAi expression (59,
60) [e.g., autoimmune and neurological diseases (61)]. miRNA-
based knockdown models seem ideally suited to study the disease
implications of allelic (e.g., single nucleotide) mutations in disease
susceptibility genes. Partial knockdown of protein function also
resembles pharmacological blockade more closely than complete
ablation of a given protein. Many KO phenotypes in mice are
known to be strictly strain-specific because of background genes
and/or compensation (58); using outbred rat strains, such as
Sprague–Dawley, avoids this problem and guarantees amuchmore
bias-free model. In addition, endogenous miRNAs can easily be
studied with this technology. Finally, using polycistronic constructs
for targeting multiple transcripts, replacing the CAG promoter by
cell type-specific promoters, or combining the Cre/loxP or Tet
system can further enlarge the spectrum of applications of this
promising technology.
Materials and Methods
Detailed descriptions of experimental procedures can be found in SIMaterials
and Methods. A brief summary of materials and methods is give here.
Generation and Molecular Characterization of Transgenic Rats. siRNAs tar-
geting Nogo-A–specific exon 3 of Rtn4 were designed and cloned into
the Pol II-driven vector pCAG-INTRON-EGFP. The construct pCAG-INTRON-
(miRNA Nogo-A)-EGFP was tested by transfections of 3T3 cells using fluores-
cent microscopy and Nogo-A mRNA measurements with real-time qPCR. The
linearized vector was used for the generation of transgenic Sprague–Dawley
rats denominated SD-Tg(CAG-RNAi:Nogo-A,EGFP)#ZI, where # stands for the
number of the transgenic line (in this work, it is abbreviated as L#). Quanti-
fication of processed miRNA and analyses of the endogenous mRNA expres-
sion levels in transgenic and WT animals were determined by qPCR. Protein
levels of Nogo-A, Nogo-B, EGFP, and housekeeping genes were measured
qualitatively and quantitatively by near-fluorescent Western blotting and
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Fig. 5. Hippocampal as well as cortical LTP are increased in Nogo-A knock-
down rats. (A) Input–output relationships (I/O curves) from WT (n = 6) and L2
Nogo-A knockdown rats (n = 6) recorded in the hippocampal CA3-CA1 Schaffer
collateral pathway. I/O curves indicate no significant difference in synaptic
strength across stimulation intensities. (B) Paired pulsed ratio measured at dif-
ferent interstimulus intervals did not significantly differ between WT and L2
(n = 6 each). (C) LTP was induced by TBS (arrow) in L2 and WT rats. At 60 min
after TBS, a significant difference between L2 and WT rats could be observed.
Inset shows original traces from representative individual experiments; numbers
correspond to the time point when traces were taken. (D) I/O curves from WT
(n = 15) and L2 Nogo-A knockdown rats (n = 15) recorded in layer II/III hori-
zontal connections in the M1 forelimb area of brain slices. I/O curves indicate
no significant difference in synaptic strength across stimulation intensities. (E)
Maximum synaptic strength (LTP saturation) was determined by repeated in-
duction of LTP (multiple arrows). Peak amplitudes were significantly larger in L2
(n = 16) compared with WT rats (n = 15). Each field potential trace represents
an average of 10 individual responses at times indicated by numbers.
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immunohistochemistry using epifluorescence and confocal microscopy. Copy
number quantification of transgenes per cell was done by genomic qPCR.
Behavioral Analysis. For the behavioral assessment, 6-mo-old male L2 (n = 10) or
WT littermate (n = 10) rats were used. The following behaviors were analyzed:
basal locomotor activity, object recognition and relocation memory, reversal
learning, PPI of the acoustic startle response, and social interaction (contact
behavior, social exploration, and approach/following; social evade; and self-
grooming behavior).
Cortical and Hippocampal LTP. Differences in LTP were measured in hippo-
campal (n: L2 = 4; WT = 4) and primary motor cortical slices (n: L2 = 16; WT =
15) of L2 rats and WT littermates, respectively.
Statistical Analysis. Statistical significance was calculated by means of un-
paired, two-tailed Student t tests if not indicated otherwise.
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